Fabrizio Fabrizi1, Francesca M Donato2, Piergiorgio Messa1. 1. Division of Nephrology Maggiore Hospital and IRCCS Foundation, Milano, Italy. 2. Division of Gastroenterology, Maggiore Hospital and IRCCS Foundation, Milano, Italy.
Abstract
Background. Hepatitis B virus infection and chronic kidney disease are prevalent and remain a major public health problem worldwide. It remains unclear how infection with hepatitis B virus impacts on the development and progression of chronic kidney disease. AIM: To evaluate the effect of infection with HBV on the risk of chronic kidney disease in the general population. MATERIAL AND METHODS: We conducted a systematic review of the published medical literature to determine if hepatitis B infection is associated with increased likelihood of chronic kidney disease. We used the random effects model of DerSimonian and Laird to generate a summary estimate of the relative risk for chronic kidney disease (defined by reduced glomerular filtration rate and/or detectable proteinuria) with hepatitis B virus across the published studies. Meta-regression and stratified analysis were also conducted. RESULTS: We identified 16 studies (n = 394,664 patients) and separate meta-analyses were performed according to the outcome. The subset of longitudinal studies addressing ESRD (n = 2; n = 91,656) gave a pooled aHR 3.87 (95% CI, 1.48; 6.25, P < 0.0001) among HBV-infected patients and no heterogeneity was recorded. In meta-regression, we noted the impact of male (P = 0.006) and duration of follow- up (P = 0.007) upon the adjusted hazard ratio of incidence of chronic kidney disease (including end-stage renal disease). No relationship occurred between HBV positive status and prevalent chronic disease (n = 7, n = 109,889 unique patients); adjusted odds ratio, were 1.07 (95% CI, 0.89; 1.25) and 0.93 (95% CI, 0.76; 1.10), respectively. CONCLUSIONS: HBV infection is possibly associated with a risk of developing reduced glomerular filtration rate in the general population; no link between HBV sero-positive status and frequency of chronic kidney disease or proteinuria was noted in cross-sectional surveys.
Background. Hepatitis B virus infection and chronic kidney disease are prevalent and remain a major public health problem worldwide. It remains unclear how infection with hepatitis B virus impacts on the development and progression of chronic kidney disease. AIM: To evaluate the effect of infection with HBV on the risk of chronic kidney disease in the general population. MATERIAL AND METHODS: We conducted a systematic review of the published medical literature to determine if hepatitis B infection is associated with increased likelihood of chronic kidney disease. We used the random effects model of DerSimonian and Laird to generate a summary estimate of the relative risk for chronic kidney disease (defined by reduced glomerular filtration rate and/or detectable proteinuria) with hepatitis B virus across the published studies. Meta-regression and stratified analysis were also conducted. RESULTS: We identified 16 studies (n = 394,664 patients) and separate meta-analyses were performed according to the outcome. The subset of longitudinal studies addressing ESRD (n = 2; n = 91,656) gave a pooled aHR 3.87 (95% CI, 1.48; 6.25, P < 0.0001) among HBV-infectedpatients and no heterogeneity was recorded. In meta-regression, we noted the impact of male (P = 0.006) and duration of follow- up (P = 0.007) upon the adjusted hazard ratio of incidence of chronic kidney disease (including end-stage renal disease). No relationship occurred between HBV positive status and prevalent chronic disease (n = 7, n = 109,889 unique patients); adjusted odds ratio, were 1.07 (95% CI, 0.89; 1.25) and 0.93 (95% CI, 0.76; 1.10), respectively. CONCLUSIONS:HBV infection is possibly associated with a risk of developing reduced glomerular filtration rate in the general population; no link between HBV sero-positive status and frequency of chronic kidney disease or proteinuria was noted in cross-sectional surveys.
Authors: Sung-Eun Kim; Eun Sun Jang; Moran Ki; Geum-Youn Gwak; Kyung-Ah Kim; Gi-Ae Kim; Do Young Kim; Dong Joon Kim; Man Woo Kim; Yun Soo Kim; Young Seok Kim; In Hee Kim; Chang Wook Kim; Ho Dong Kim; Hyung Joon Kim; Neung Hwa Park; Soon Koo Baik; Jeong Ill Suh; Byung-Cheol Song; Il Han Song; Jong Eun Yeon; Byung Seok Lee; Youn Jae Lee; Young Kul Jung; Woo Jin Chung; Sung Bum Cho; Eun-Young Cho; Hyun Chin Cho; Gab Jin Cheon; Hee Bok Chae; DaeHee Choi; Sung-Kyu Choi; Hwa Young Choi; Won Young Tak; Jeong Heo; Sook-Hyang Jeong Journal: J Korean Med Sci Date: 2018-09-12 Impact factor: 2.153
Authors: Anne Liu; An Le; Jian Zhang; Chris Wong; Clifford Wong; Linda Henry; Mindie H Nguyen Journal: Clin Transl Gastroenterol Date: 2018-03-14 Impact factor: 4.488
Authors: Ye Du; Shikun Zhang; Mei Hu; Qiaomei Wang; Na Liu; Haiping Shen; Yiping Zhang; Donghai Yan; Man Zhang Journal: Medicine (Baltimore) Date: 2019-02 Impact factor: 1.817